Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended July 31, 1998
Business Overview: Manufacturer of steel and wood laboratory furniture and technical products.
Key Financial Metrics
| Metric ($ in thousands) | Q1 1999 (Ended July 31, 1998) | Q1 1998 (Ended July 31, 1997) |
|---|---|---|
| Net Sales | $19,624 | $17,662 |
| Gross Profit | $4,422 | $4,138 |
| Gross Margin | 22.5% | 23.4% |
| Operating Earnings | $1,299 | $972 |
| Net Earnings | $766 | $559 |
| Diluted EPS | $0.31 | $0.23 |
| Operating Cash Flow | ($141) Used | ($1,016) Used |
| Capital Expenditures | ($1,118) | ($45) |
| Cash and Equivalents (End of Period) | $471 | $30 |
| Working Capital | $9,517 | N/A |
| Debt (Revolving Credit Facility) | $0 | $0 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 11.1% to $19.6 million, driven by higher unit sales of steel and wood laboratory furniture, partially offset by lower technical product sales.
- Profitability: Net earnings rose 37% to $766,000. Operating earnings increased to $1.3 million.
- Margins: Gross profit margin declined to 22.5% from 23.4% due to product mix differences. Operating expenses as a percentage of sales improved to 15.9% from 17.9%, primarily due to lower sales commissions.
- Interest Expense: Decreased significantly to $12,000 from $52,000 due to lower debt levels under the revolving credit facility.
- Cash Flow: Operating cash outflow improved significantly to $141,000 from $1.0 million in the prior year, aided by a decrease in inventory levels.
Outlook, Risks, and Management Commentary
- Liquidity: Management believes funds from operations and short-term borrowings are sufficient to support ongoing business and capital expenditures through the fiscal year. The current ratio improved to 1.9-to-1.
- Capital Expenditures: The company spent $1.1 million on production equipment this quarter compared to $45,000 last year. No abnormal level of capital expenditures is anticipated for the remainder of the fiscal year.
- Year 2000 Compliance: Main business applications are compliant. A target date of April 30, 1999, is set for full compliance and contingency planning. Management does not expect significant costs or material impact on profitability.
- Accounting Standards: The company is evaluating the impact of SFAS No. 131 regarding segment disclosures, to be adopted in fiscal 1999.
- Risks: Forward-looking statements are subject to economic, competitive, and technological risks. Potential Year 2000 failures by suppliers or customers could adversely affect business.
Investor Verification Checklist
- Verify the sustainability of the 11.1% sales growth given the shift in product mix (furniture vs. technical products).
- Confirm the impact of the $1.1 million capital expenditure on future production capacity and depreciation.
- Monitor the Year 2000 compliance status of significant suppliers and customers, as the company lacks a formal contingency plan for external entities.
- Review the trend in operating cash flow, which remains negative for the quarter despite improved earnings.
- Assess the effect of SFAS No. 131 adoption on future segment reporting and transparency.